Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118335792 | 11833579 | 2 | F | 20160628 | 20151214 | 20160712 | EXP | US-TEVA-617515USA | TEVA | GOLOMB BA, KOSLIK HJ, REDD AJ. FLUOROQUINOLONE-INDUCED SERIOUS, PERSISTENT, MULTISYMPTOM ADVERSE EFFECTS. BMJ-CASE-REP 2015; :. | 46.00 | YR | M | Y | 0.00000 | 20160712 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118335792 | 11833579 | 1 | PS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | 750 MG/DAY FOR 21 DAYS | N | 76361 | |||||||||
| 118335792 | 11833579 | 2 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 118335792 | 11833579 | 3 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118335792 | 11833579 | 1 | Epididymitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118335792 | 11833579 | OT |
| 118335792 | 11833579 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118335792 | 11833579 | Affective disorder | |
| 118335792 | 11833579 | Anxiety | |
| 118335792 | 11833579 | Arthralgia | |
| 118335792 | 11833579 | Atrophy | |
| 118335792 | 11833579 | Bradycardia | |
| 118335792 | 11833579 | Cognitive disorder | |
| 118335792 | 11833579 | Eye disorder | |
| 118335792 | 11833579 | Fatigue | |
| 118335792 | 11833579 | Fibromyalgia | |
| 118335792 | 11833579 | Gastrointestinal disorder | |
| 118335792 | 11833579 | Gastrointestinal motility disorder | |
| 118335792 | 11833579 | Muscle atrophy | |
| 118335792 | 11833579 | Muscular weakness | |
| 118335792 | 11833579 | Myalgia | |
| 118335792 | 11833579 | Neuropathy peripheral | |
| 118335792 | 11833579 | Polyneuropathy | |
| 118335792 | 11833579 | Respiratory muscle weakness | |
| 118335792 | 11833579 | Tachycardia | |
| 118335792 | 11833579 | Tendon disorder | |
| 118335792 | 11833579 | Toxicity to various agents | |
| 118335792 | 11833579 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |